# GE Healthcare and GMS Taiwan sign exclusive license agreement for Vizamyl in Taiwan

GE Healthcare and Global Medical Solutions Taiwan signed an exclusive license agreement to manufacture and commercialize Flutemetamol F-18 Injection (Vizamyl) in Taiwan. GMS Taiwan plans to file an NDA by end of 2021.

- Type: Contract
- Announced: 2021-04-12
- Where: Taiwan, TWN
- Status: announced
- Products: Flutemetamol F-18 Injection (Vizamyl), radioactive diagnostic agent for PET imaging
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GE Healthcare](https://endata.com/companies/4246.md) (partner)
- [Global Medical Solutions Taiwan](https://endata.com/companies/35627.md) (partner)

## Sources

- [globalmedicalsolutions.com](https://globalmedicalsolutions.com/2021/04/12/gehc-and-gmst-exclusive-license-agreement-flutemetamol-f-18/), 2021-04-12: "GE Healthcare and Global Medical Solutions Taiwan have signed an exclusive license agreement to manufacture and commercialize Flutemetamol F-18 Injection in Taiwan."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.